P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells

P04-36. HIV-1-speficic antibody dependant cellular cytotoxicity (ADCC) médiated by primary NK cells

Bibliographic Details
Main Authors:	Penichon J, Decoville T, Holl V, Delaporte M, Moog C
Format:	Article
Language:	English
Published:	BMC 2009-10-01
Series:	Retrovirology

Similar Items

P04-29. HIV-1 neutralizing antibodies inhibit plasmacytoid dendritic cells infection
by: Moog C, et al.
Published: (2009-10-01)

Natural killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) in tumour immunotherapy with therapeutic antibodies
by: Ursula Jördis Eva Seidel, et al.
Published: (2013-03-01)

Novel TLR 7/8 agonists for improving NK cell mediated antibody-dependent cellular cytotoxicity (ADCC)
by: Vidhi Khanna, et al.
Published: (2021-02-01)

A mathematical model of antibody-dependent cellular cytotoxicity (ADCC)
by: Hoffman, F, et al.
Published: (2017)

HIV-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) -Mediating Antibodies Decline while NK Cell Function Increases during Antiretroviral Therapy (ART).
by: Sanne Skov Jensen, et al.
Published: (2015-01-01)

KIR/HLA genotype combinations are determinants of Natural Killer (NK) cell mediated antibody-dependent cellular cytotoxicity (ADCC) potency
by: Parsons MS, et al.
Published: (2012-09-01)

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
by: Dieter Mielke, et al.
Published: (2019-12-01)

P04-27. Monoclonal neutralizing antibodies inhibit HIV-1 transfer from immature dendritic cells to human primary CD4 T-lymphocytes
by: Aubertin A, et al.
Published: (2009-10-01)

Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)
by: Jennifer J.-J. Tang, et al.
Published: (2020-10-01)

Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood
by: Okazaki Akira, et al.
Published: (2009-02-01)

Peculiarities detected in formation of speficic hapten sensitization to phenol in children
by: O.V. Dolgikh, et al.
Published: (2022-03-01)

Presence of antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 in COVID-19 plasma.
by: For Yue Tso, et al.
Published: (2021-01-01)

Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity
by: Nicole F. Bernard, et al.
Published: (2017-08-01)

Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus
by: Ryan Yucha, et al.
Published: (2023-10-01)

Considerations of Antibody Geometric Constraints on NK Cell Antibody Dependent Cellular Cytotoxicity
by: Charles D. Murin
Published: (2020-07-01)

Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells
by: Kate J. Dixon, et al.
Published: (2021-01-01)

NK cell mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
by: Wei eWang, et al.
Published: (2015-07-01)

A Human Anti-M2 Antibody Mediates Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Cytokine Secretion by Resting and Cytokine-Preactivated Natural Killer (NK) Cells.
by: Venkateswara R Simhadri, et al.
Published: (2015-01-01)

The importance of antibody dependent cell-mediated cytotoxicity (ADCC) for breast cancer response to trastuzumab - Herceptin
by: Juranić Zorica D., et al.
Published: (2002-01-01)

Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity
by: Zhaoming Wang, et al.
Published: (2021-12-01)

Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition
by: Kathleen E. Fenerty, et al.
Published: (2018-11-01)

FcγRIIIa receptor polymorphism influences NK cell mediated ADCC activity against HIV
by: Sneha Pramod Talathi, et al.
Published: (2019-12-01)

A Tridimensional Model for NK Cell-Mediated ADCC of Follicular Lymphoma
by: Emilie Decaup, et al.
Published: (2019-08-01)

The Yin and Yang of ADCC-Mediating Antibodies
by: Marjorie Robert-Guroff
Published: (2016-01-01)

P10-07. Extremely rapid degranulation of NK cells activated by HIV-specific antibody dependent cellular cytotoxicity
by: Stratov I, et al.
Published: (2009-10-01)

Impact of HIV-1 Vpu-mediated downregulation of CD48 on NK-cell-mediated antibody-dependent cellular cytotoxicity
by: Lorie Marchitto, et al.
Published: (2023-08-01)

Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition
by: Kathleen E. Fenerty, et al.
Published: (2019-09-01)

887 In vivo evaluation of the role of T cell help in NK cell mediated ADCC
by: George J Weiner, et al.
Published: (2023-11-01)

919 Exploring new strategies for improved ADCC responses with humanized NK cells
by: Xiang Gao, et al.
Published: (2023-11-01)

“Universal Flu Vaccine”: Can NK Cell-mediated ADCC Tip the Scales?
by: Maya Hassane, et al.
Published: (2016-06-01)

Compromised NK cell-mediated antibody-dependent cellular cytotoxicity in chronic SIV/SHIV infection.
by: Xuan He, et al.
Published: (2013-01-01)

The Contribution of IgG Glycosylation to Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) and Complement-Dependent Cytotoxicity (CDC) in Hashimoto’s Thyroiditis: An in Vitro Model of Thyroid Autoimmunity
by: Marta Ząbczyńska, et al.
Published: (2020-01-01)

ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response
by: Femke A. I. Ehlers, et al.
Published: (2021-06-01)

Reconstruction of a polyclonal ADCC antibody repertoire from an HIV-1 non-transmitting mother
by: Zak A. Yaffe, et al.
Published: (2023-05-01)

NK cells inhibit Plasmodium falciparum growth in red blood cells via antibody-dependent cellular cytotoxicity
by: Gunjan Arora, et al.
Published: (2018-06-01)

γδT cells are ADCC effectors in elite HIV controllers
by: Armstrong Cheryl, et al.
Published: (2010-05-01)

LIR‐1 educates expanded human NK cells and defines a unique antitumor NK cell subset with potent antibody‐dependent cellular cytotoxicity
by: Caroline Leijonhufvud, et al.
Published: (2021-01-01)

Paradox of Protection: Preferential Recognition of CD4-induced Epitopes by Anti-HIV-1 ADCC Antibodies
by: Matthew S. Parsons, et al.
Published: (2015-10-01)

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection
by: Dieter Mielke, et al.
Published: (2021-11-01)

ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.
by: Dieter Mielke, et al.
Published: (2021-11-01)